# Interview with IXICO & GAP Foundation 7 Dec 21 blog # Interview with IXICO & GAP Foundation Partnerships [ ](https://x.com/intent/tweet?url=https://ixico.com/news-and-resources/blog/interview-with-ixico-and-gap-foundation/) [ ](https://bsky.app/intent/compose?text=https://ixico.com/news-and-resources/blog/interview-with-ixico-and-gap-foundation/) [ ](https://www.facebook.com/sharer/sharer.php?u=https://ixico.com/news-and-resources/blog/interview-with-ixico-and-gap-foundation/) [ ](https://www.linkedin.com/shareArticle?mini=true&url=https://ixico.com/news-and-resources/blog/interview-with-ixico-and-gap-foundation/) [ Play Video ](https://youtube.com/watch?v=78wmCjtbbhg "Play Video") We are delighted to be working with the [Global Alzheimer's Platform Foundation](https://www.linkedin.com/company/global-alzheimer's-platform-foundation/) and their industry partners for the pioneering Bio-Hermes study. Watch the interview with IXICO's clinical development advisor Lynne Hughes and President of GAP John Dwyer as they discuss this partnership and the study. [ Back to Blog ](/news-and-resources/blog/) ### Recents ![Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials](/assets/blog-images/Alzheimers-biomarkers__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) 29 Sep 26 blog [Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/) [White matter hyperintensities: A precision neurology tool for Alzheimer’s patient stratification and improved trial sensitivity? ](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/) [Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/) [From Information to Intelligence: New Platform Identity Explained](/news-and-resources/blog/from-information-to-intelligence-bram-goodren-ceo-of-ixico-explains-the-new-identity-of-the-ixi-platform-and-why-it-matters/) [Advancing HD Clinical Trials with Automated Imaging: What the Latest Research Shows](/news-and-resources/blog/advancing-hd-clinical-trials-with-automated-imaging-what-the-latest-research-shows/) ### Library [November 2026](/news-and-resources/blog/archive/2026/11/) [October 2026](/news-and-resources/blog/archive/2026/10/) [September 2026](/news-and-resources/blog/archive/2026/09/) [July 2026](/news-and-resources/blog/archive/2026/07/) [June 2026](/news-and-resources/blog/archive/2026/06/) [May 2026](/news-and-resources/blog/archive/2026/05/) [April 2026](/news-and-resources/blog/archive/2026/04/) [March 2026](/news-and-resources/blog/archive/2026/03/) [February 2026](/news-and-resources/blog/archive/2026/02/) [January 2026](/news-and-resources/blog/archive/2026/01/) [2025](/news-and-resources/blog/archive/2025/) [2024](/news-and-resources/blog/archive/2024/) [2023](/news-and-resources/blog/archive/2023/) [2022](/news-and-resources/blog/archive/2022/) [2021](/news-and-resources/blog/archive/2021/) [2020](/news-and-resources/blog/archive/2020/) [2019](/news-and-resources/blog/archive/2019/)